Prednisone is an oral corticosteroid used for inflammatory and autoimmune conditions when the immune response needs to be reduced. It acts like cortisol, helping control swelling, pain, allergic reactions, and immune activity. Treatment is tailored to the condition, dose, duration, age, other medicines, and health history.
Prednisone is a synthetic corticosteroid and steroid hormone. The liver converts it into prednisolone, the active form that binds to glucocorticoid receptors inside cells. Prednisone belongs to the wider group of steroid medicines and immunosuppressive medicines.
Its recognised clinical role is described in the FDA prescribing information for prednisone tablets [1].
Prednisone tablets are taken by mouth with the prescribed dose and frequency. The treatment duration can range from a brief course to long-term therapy, depending on the indication.
Prednisone can suppress the hypothalamic–pituitary–adrenal axis. This system normally signals the adrenal glands to produce cortisol. After prolonged or high-dose treatment, the body may need time to resume normal cortisol production.
A taper gradually reduces the dose so that adrenal recovery can occur while the original disease remains controlled. There is no single taper schedule suitable for every person. The plan considers the starting dose, treatment duration, underlying illness, relapse risk, current symptoms, and signs of adrenal suppression.
Stopping abruptly after a prolonged course may cause severe fatigue, weakness, dizziness, nausea, low blood pressure, joint or muscle pain, or a return of the treated disease. A taper may need to pause or become slower when symptoms return.
Prednisone is supplied as oral tablets. The active substance is prednisone, and the tablet strength determines how much corticosteroid is taken at each dose.
The liver converts it into prednisolone, the active form that binds to glucocorticoid receptors inside cells. This changes the production of inflammatory proteins and reduces the activity of immune cells.
Corticosteroids act at cellular level. They reduce inflammatory signalling, limit immune-cell migration into affected tissues, and decrease the release of substances that cause swelling, redness, pain, itching, and tissue irritation.
Prednisone is used when inflammation or immune activity contributes to symptoms or tissue damage. Medical specialties that may use it include rheumatology, pulmonology, dermatology, gastroenterology, haematology, allergy medicine, and transplant medicine.
Possible clinical uses include:
Prednisone may be given with other immunosuppressive medicines when one drug cannot provide sufficient control. The treatment plan depends on the disease, organ involvement, infection risk, and previous response to corticosteroids.
The dose is decided individually, taking age, other medicines, and health conditions into account. A high dose may be used for a short period, while a lower dose may continue for longer when disease control requires it.
Several practical errors can reduce treatment control or increase side effects. Do not share tablets.
A common misconception is that a short improvement means the illness has permanently cleared. Prednisone can suppress inflammation quickly while the underlying autoimmune or inflammatory process remains active.
Prednisone is not suitable for everyone. The treatment may be inappropriate, require specialist oversight, or need additional monitoring in people with:
Prednisone can interact with medicines that affect infection risk, blood glucose, blood pressure, stomach protection, clotting, seizure control, and steroid metabolism. Examples include anticoagulants, non-steroidal anti-inflammatory drugs, certain diabetes medicines, some antifungals, and medicines that alter liver enzyme activity.
NOT for you if a clinician has identified a serious untreated fungal infection, a severe steroid reaction, or another contraindication requiring an alternative treatment. Tell your prescriber if you have diabetes, high blood pressure, heart failure, an ulcer, osteoporosis, glaucoma, tuberculosis, another infection, or a history of severe mood problems. Ask for medical advice before receiving a live vaccine while taking Prednisone.
Prednisone side effects depend on dose, duration, age, susceptibility, and other medicines. Short courses can still cause insomnia, mood changes, indigestion, increased appetite, fluid retention, or a rise in blood glucose. Long-term treatment increases the risk of complications affecting bones, eyes, muscles, skin, metabolism, and adrenal function.
| Time pattern | Possible effects |
|---|---|
| Short-term use | Indigestion, insomnia, increased appetite, mood changes, fluid retention, raised blood glucose |
| Longer or higher-dose use | Weight gain, high blood pressure, osteoporosis, cataracts, glaucoma, muscle weakness, adrenal suppression |
| Urgent symptoms | Severe infection, marked mood disturbance, vision changes, black stools, allergic reaction, severe weakness |
Increased appetite can lead to weight gain. Prednisone may also cause fluid and sodium retention, which can raise blood pressure or worsen swelling in susceptible people. High doses may produce steroid-induced diabetes or reveal previously unrecognised diabetes by increasing blood glucose.
People with diabetes may need closer glucose monitoring during treatment. Thirst, frequent urination, unusual tiredness, blurred vision, or unexplained weight loss can indicate significant hyperglycaemia.
Prednisone can cause vision changes and may contribute to cataracts or glaucoma, especially during prolonged treatment. New visual blurring, eye pain, halos around lights, or loss of vision requires prompt assessment.
Long-term use can reduce bone density and raise fracture risk. It can also cause thinner skin, easy bruising, acne, slower wound healing, and muscle weakness. Mood changes range from irritability and anxiety to depression, agitation, mania, or rarely psychosis.
One practical detail is easy to miss: taking Prednisone late in the day may worsen insomnia. Another is that reduced inflammation can mask infection symptoms, so worsening pain, cough, urinary symptoms, or a wound problem deserves attention even without a high fever.
Prednisone and prednisolone are closely related corticosteroids. Prednisone requires conversion in the liver, while prednisolone is already in its active form. This difference may influence selection in people with significant liver impairment or when a more predictable active drug concentration is needed.
| Treatment | Main pharmacological feature | Clinical consideration |
|---|---|---|
| Prednisone | Converted to prednisolone in the liver | Common oral corticosteroid option when hepatic conversion is adequate |
| Prednisolone | Active glucocorticoid form | May be preferred when conversion of prednisone could be unreliable |
| Corticosteroid-sparing plan | Uses non-steroid therapy to reduce steroid exposure | May lower long-term steroid toxicity but may not control every flare |
The two corticosteroids are not interchangeable milligram for milligram without a planned conversion. A clinician may also choose a steroid-sparing immunosuppressive medicine when long-term Prednisone risks become difficult to manage.
In clinical practice, doctors usually judge Prednisone by two outcomes: whether it controls the inflammatory disease and whether the dose can be reduced safely. Improvement in pain, breathing, rash, bowel symptoms, or swelling does not prove that the underlying condition has resolved.
Physicians also look for treatment toxicity. Blood pressure, weight, glucose, infection symptoms, bone health, mood, and eyesight may all become relevant during longer courses. The MHRA has highlighted psychiatric effects associated with systemic corticosteroids [2].
A clinician will often use the lowest dose that maintains disease control. The lowest dose is not always the same as the smallest tablet strength, because the appropriate regimen may include alternating doses, staged reductions, or temporary increases during a flare.
After prolonged or high-dose treatment, the adrenal glands may not produce enough cortisol immediately. Sudden withdrawal can cause weakness, dizziness, nausea, low blood pressure, and a return of inflammation. NHS and MHRA corticosteroid guidance available before 2026 supports gradual, individualised tapering when adrenal suppression is possible. The dose should be reduced according to the prescribed plan, not according to symptom improvement alone.
Severe allergic swelling, breathing difficulty, confusion, black stools, severe abdominal pain, marked weakness, serious vision changes, or rapidly worsening infection symptoms need urgent assessment. Prednisone should not be stopped abruptly after prolonged treatment unless the treating clinician gives an emergency instruction, because withdrawal can itself be dangerous. MHRA safety information from 2024 links systemic corticosteroids with psychiatric, metabolic, infection-related, and adrenal complications that require prompt recognition.
The correct action depends on how close the missed dose is to the next scheduled dose and on the treatment schedule. A missed dose should not automatically be replaced with two doses together, especially when Prednisone is being used in a taper or transplant regimen. The EMA product-information framework used in 2025 advises following the prescribed missed-dose instruction and seeking prompt guidance when several doses have been missed.
Prednisone may be used in pregnancy or breastfeeding when the expected clinical benefit justifies exposure and a clinician has selected the regimen. The dose and treatment duration matter, and the underlying inflammatory disease may also pose risks if untreated. UKTIS information reviewed in 2025 and guidance used by the NHS describe corticosteroid decisions as individualised, with observation of the infant sometimes needed during prolonged maternal treatment.
Prednisone is converted by the liver into prednisolone, while prednisolone is already active. This can influence treatment choice in significant liver disease or when a clinician wants to avoid relying on hepatic conversion. EMA corticosteroid information from 2023 supports treating the two drugs as related but not automatically interchangeable; dose conversion must be prescribed.
Alcohol can worsen stomach irritation and may increase the risk of gastrointestinal bleeding when combined with Prednisone and non-steroidal anti-inflammatory drugs. It can also aggravate insomnia, mood changes, high blood glucose, and blood pressure problems in susceptible people. NHS medicine guidance available in 2025 advises limiting alcohol when corticosteroid-related stomach or mood effects are present, especially during prolonged treatment.
An untreated serious systemic fungal infection is a clear situation in which Prednisone may be unsuitable because immune suppression can allow the infection to worsen. Other conditions, including uncontrolled diabetes, severe glaucoma, active tuberculosis, or a previous serious steroid reaction, may require specialist alternatives or close monitoring rather than automatically excluding treatment. MHRA information from 2024 supports reviewing infection history and major comorbidities before systemic corticosteroid therapy begins.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
The swelling eased within a few days, and I could move more comfortably. I had trouble sleeping and felt hungrier than usual, so taking it early helped. The taper was slower than I expected.
Breathing symptoms improved, but I noticed a metallic taste and felt restless at night. The medicine helped, although the first week was uncomfortable. My glucose readings were higher than usual and settled after the course ended.
The treatment reduced the morning stiffness considerably. Weight gain became frustrating over several months, and my blood pressure needed closer monitoring. I did not stop suddenly because the taper had been explained carefully.
The rash settled quickly, which was a relief. I also became irritable and slept badly for several nights. A dose adjustment improved that, but the medicine was not something I wanted to continue longer than necessary.
Prednisone controlled the symptoms, but I developed blurred vision that needed checking. The eye assessment was reassuring, yet it reminded me that side effects should be reported rather than ignored.
